BioSpace News Archive

PanAmerican Clinical Research, delivering research and patient recruitment services in South, Central, and North America, adds Mitchell Parrish and Kraig Keeter to its executive leadership team.

US Radiology Specialists announced today a new partnership with Upstate Carolina Radiology (UCR), a leading physician-owned provider of high-quality diagnostic and interventional radiology services in upstate South Carolina

To continue on the path of strategic growth, Ideal Image, the nation’s leading MedSpa specializing in non-invasive, non-surgical aesthetic treatments, announced today that Yogi Jashnani has joined the company’s executive leadership team as the new Chief Commercial Officer (CCO), effective immediately.

The home care industry is entering a transformative decade ahead. At least 10,000 baby boomers will turn 65 every day until 2029, and the U.S. will need to hire 2.3 million new healthcare workers to care for this aging population by 2025.

Gracell Biotechnologies Co., Ltd. (“Gracell”), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed using TruUCAR™ to treat relapsed or refractory (R/R) T-cell malignancies.

Ferring Pharmaceuticals and CCRM announced the launch of Fertility House Calls, in the Greater Denver metro area, a new service that provides a simple, convenient way to explore fertility treatment options from your home.

RedHawk Holdings Corp. announced the engagement of Valerie Allen Public Relations to assist the Company in developing its awareness campaign for its Sharps and Needle Disintegration Devices, a proprietary line of FDA-approved and OSHA-compliant needle incineration medical devices used for the safe, economical and environmentally friendly incineration and disposal of hypodermic needles.

Pieces Technologies (“Pieces” or the “Company”), a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health, announced today that it has closed a $25.7 million Series B funding round led by healthcare investment firm Concord Health Partners.

TwinStrand Biosciences™, a novel genetic sequencing technology company, today announced the close of $16 million in Series A funding, including $12 million in new capital. Madrona Venture Group led the investment with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures

The 18th year of partnership marks the largest donation to date by Burlington to help those affected by blood cancer